Target intelligence / Profile preview

Long intergenic non-protein coding RNA 240 (LINC00240)

Target
LINC00240
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 240 (LINC00240) is a human long non-coding RNA gene located at 6p22.2 (chromosome 6:26956915-27059749). It is not translated into protein but plays regulatory roles in gene expression. LINC00240 acts as a competitive endogenous RNA, binding and sequestering microRNAs such as miR-7-5p and miR-338-5p, which in turn influences key signaling molecules like EGFR in lung cancer and METTL3 in gastric cancer. LINC00240 promotes cancer cell proliferation, migration, and invasion, and its high expression is associated with more advanced tumor stages and poorer prognosis. It is emerging as a potential target for therapeutic intervention and/or biomarker in specific cancers, although no drugs directly targeting LINC00240 are in clinical use per current literature.

Other names
bA373D17.1C6orf41NCRNA00240LINC00240
02

Mechanism of action

Molecular sponge: Binds and sequesters specific microRNAs including miR-7-5p and miR-338-5p, derepressing their target genes (such as EGFR and METTL3), leading to increased cell proliferation, migration, and invasion

03

Biological functions

Regulation of cell proliferationRegulation of cell migration and invasionCell apoptosis modulationActs as a molecular sponge (competitive endogenous RNA, or ceRNA) for microRNAs (miRNAs), influencing downstream gene expression
04

Disease associations

Cancer (especially lung cancer, gastric cancer, cervical cancer, esophageal cancer)Other
05

Safety considerations

None directly reported; as LINC00240 is non-coding, any safety concerns would relate to potential off-target consequences of modulating lncRNA function in complex regulatory networks
06

Biomarkers

LINC00240 expression itself may serve as a biomarker for prognosis in cancers (elevated in gastric cancer patients with shorter overall survival)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 240 (LINC00240).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 240 (LINC00240).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call